ÌÇÐÄÆÆ½â°æ

Small and medium-sized biotech companies

Statistics report about small and medium-sized innovative biotech companies

This report presents key facts and figures on small and mid-sized biotech companies which are the key driver of innovation for the whole biopharma sector. Small and mid-sized enterprises (SMEs) are responsible for most of the new breakthrough therapies and technologies. This report provides a good introduction into the biotech SME landscape, thereby focusing on two SMEs which made it to the big scene due to their COVID-19 vaccines: BioNTech and Moderna.

Table of contents

Biotech market

6
  • Basic Statistic Percentage of global pharmaceutical sales by technology 2016-2030
  • Premium Statistic Global biotech drug sales estimate 2012-2024
  • Premium Statistic Major pharma and biotech drug launches in 2026, by revenue estimates for 2032
  • Basic Statistic Enterprise value change in biopharma subsectors worldwide 2025-2026
  • Basic Statistic Sales per employee of select U.S. biotech and drug companies Q3-Q4 2025
  • Premium Statistic Gross profit margin of select U.S. biotech and drug companies Q1-Q4 2025

SME financing

6
  • Basic Statistic Total raised capital in U.S. and Europe biotechnology industry 2015-2024
  • Premium Statistic IPOs in U.S. and Europe biotechnology industry 2015-2024
  • Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2024
  • Basic Statistic United States biotech financing data 2015-2020
  • Premium Statistic Value of top U.S. biotech IPOs 2024
  • Basic Statistic U.S. investment for emerging therapeutic companies 2011-2023

Research & development

5
  • Basic Statistic Leading 50 global pharmaceutical and biotech companies 2024, by R&D intensity
  • Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug owner
  • Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug originator
  • Basic Statistic Origin of new drugs licensed or acquired, 2014-2018, by company size
  • Basic Statistic Alliances U.S. and Europe biotech companies by total potential value 2024

Growth

4
  • Premium Statistic Top performing companies on Nasdaq Biotech Index 2020
  • Basic Statistic Major pharmaceutical and biotech companies in 2024, by operating profit growth
  • Premium Statistic Major pharmaceutical companies 2024, by capex growth
  • Basic Statistic Major pharmaceutical companies in R&D spending growth in 2024

BioNTech vs. Moderna

8
  • Basic Statistic Revenue of BioNTech 2017-2025
  • Basic Statistic Moderna's revenue 2016-2025
  • Basic Statistic Operating income of BioNTech 2017-2024
  • Basic Statistic Moderna net income 2016-2024
  • Basic Statistic BioNTech total assets 2017-2025
  • Basic Statistic Moderna total assets 2016-2024
  • Basic Statistic R&D expenses of BioNTech 2017-2025
  • Basic Statistic R&D expenses of Moderna 2016-2024

Comparison of COVID-19 vaccines

5
  • Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
  • Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
  • Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
  • Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
  • Basic Statistic Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.